Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Structural modifications of the salivary conditioning film upon exposure to sodium bicarbonate: implications for oral lubrication and mouthfeel.

Ash A, Wilde PJ, Bradshaw DJ, King SP, Pratten JR.

Soft Matter. 2016 Mar 14;12(10):2794-801. doi: 10.1039/c5sm01936b. Epub 2016 Feb 17.

PMID:
26883483
2.

Structural study of Al2O3-Na2O-CaO-P2O5 bioactive glasses as a function of aluminium content.

Smith JM, King SP, Barney ER, Hanna JV, Newport RJ, Pickup DM.

J Chem Phys. 2013 Jan 21;138(3):034501. doi: 10.1063/1.4774330.

PMID:
23343279
3.

Oligo-nuclear silver thiocyanate complexes with monodentate tertiary phosphine ligands, including novel 'cubane' and 'step' tetramer forms of AgSCN : PR3 (1:1)4.

Bowmaker GA, Di Nicola C, Effendy, Hanna JV, Healy PC, King SP, Marchetti F, Pettinari C, Robinson WT, Skelton BW, Sobolev AN, Tăbăcaru A, White AH.

Dalton Trans. 2013 Jan 7;42(1):277-91. doi: 10.1039/c2dt31853a.

PMID:
23114624
4.

Titanium phosphate glass microspheres for bone tissue engineering.

Lakhkar NJ, Park JH, Mordan NJ, Salih V, Wall IB, Kim HW, King SP, Hanna JV, Martin RA, Addison O, Mosselmans JF, Knowles JC.

Acta Biomater. 2012 Nov;8(11):4181-90. doi: 10.1016/j.actbio.2012.07.023. Epub 2012 Jul 24.

PMID:
22835676
5.

Mechanochemical and solution synthesis, X-ray structure and IR and 31P solid state NMR spectroscopic studies of copper(I) thiocyanate adducts with bulky monodentate tertiary phosphine ligands.

Bowmaker GA, Hanna JV, Hart RD, Healy PC, King SP, Marchetti F, Pettinari C, Skelton BW, Tabacaru A, White AH.

Dalton Trans. 2012 Jul 7;41(25):7513-25. doi: 10.1039/c2dt30579h. Epub 2012 May 22.

PMID:
22618248
6.

Effect of multiple adduct fullerenes on microstructure and phase behavior of P3HT:fullerene blend films for organic solar cells.

Guilbert AA, Reynolds LX, Bruno A, MacLachlan A, King SP, Faist MA, Pires E, Macdonald JE, Stingelin N, Haque SA, Nelson J.

ACS Nano. 2012 May 22;6(5):3868-75. doi: 10.1021/nn204996w. Epub 2012 May 3.

PMID:
22533706
7.

Evaluation of the person-centered care essentials program: importance of trainers in achieving targeted outcomes.

King SP, O'Brien CJ, Edelman P, Fazio S.

Gerontol Geriatr Educ. 2011;32(4):379-95. doi: 10.1080/02701960.2011.611552.

PMID:
22087783
8.

Structural characterization and physical properties of P2O5-CaO-Na2O-TiO2 glasses by Fourier transform infrared, Raman and solid-state magic angle spinning nuclear magnetic resonance spectroscopies.

Kiani A, Hanna JV, King SP, Rees GJ, Smith ME, Roohpour N, Salih V, Knowles JC.

Acta Biomater. 2012 Jan;8(1):333-40. doi: 10.1016/j.actbio.2011.08.025. Epub 2011 Aug 31.

9.

Solution and mechanochemical syntheses, and spectroscopic and structural studies in the silver(I) (bi-)carbonate: triphenylphosphine system.

Bowmaker GA, Effendy, Hanna JV, Healy PC, King SP, Pettinari C, Skelton BW, White AH.

Dalton Trans. 2011 Jul 21;40(27):7210-8. doi: 10.1039/c1dt10416k. Epub 2011 Jun 10.

PMID:
21660345
10.

Direct growth of metal sulfide nanoparticle networks in solid-state polymer films for hybrid inorganic-organic solar cells.

Dowland S, Lutz T, Ward A, King SP, Sudlow A, Hill MS, Molloy KC, Haque SA.

Adv Mater. 2011 Jun 24;23(24):2739-44. doi: 10.1002/adma.201100625. Epub 2011 Apr 26. No abstract available.

PMID:
21520466
11.

Criteria for selecting pharmacokinetic repeat study samples.

King SP, Aungst BJ, Shen HS.

Bioanalysis. 2009 Nov;1(8):1415-8. doi: 10.4155/bio.09.99.

PMID:
21083091
12.

Nanostructured hybrid polymer-inorganic solar cell active layers formed by controllable in situ growth of semiconducting sulfide networks.

Leventis HC, King SP, Sudlow A, Hill MS, Molloy KC, Haque SA.

Nano Lett. 2010 Apr 14;10(4):1253-8. doi: 10.1021/nl903787j.

PMID:
20225884
13.

Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations.

Fast DM, Kelley M, Viswanathan CT, O'Shaughnessy J, King SP, Chaudhary A, Weiner R, DeStefano AJ, Tang D.

AAPS J. 2009 Jun;11(2):238-41. doi: 10.1208/s12248-009-9100-9. Epub 2009 Apr 21. Review.

14.

The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis.

Savoie N, Booth BP, Bradley T, Garofolo F, Hughes NC, Hussain S, King SP, Lindsay M, Lowes S, Ormsby E, Phull R, Rocci ML Jr, Vallano PT, Viau A, Zhu Z.

Bioanalysis. 2009 Apr;1(1):19-30. doi: 10.4155/bio.09.11.

15.

Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbits.

Solon EG, Dowell JA, Lee J, King SP, Damle BD.

Antimicrob Agents Chemother. 2007 Aug;51(8):3008-10. Epub 2007 Jun 4.

16.

Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide.

Rohatagi S, Luo Y, Shen L, Guo Z, Schemm C, Huang Y, Chen K, David M, Nave R, King SP.

Am J Ther. 2005 May-Jun;12(3):201-9.

PMID:
15891262
17.

Development of the knowledge about memory loss and care (KAML-C) test.

Kuhn D, King SP, Fulton BR.

Am J Alzheimers Dis Other Demen. 2005 Jan-Feb;20(1):41-9.

PMID:
15751453
18.

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach RS, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; FDA Center for Drug Evaluation and Research (CDER).

Drug Metab Dispos. 2003 Jul;31(7):815-32.

PMID:
12814957
19.

The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working Groups.

J Clin Pharmacol. 2003 May;43(5):443-69. Review.

PMID:
12751267
20.
21.

Impact of age and gender on the pharmacokinetics of gemtuzumab ozogamicin.

Korth-Bradley JM, Dowell JA, King SP, Liu H, Berger MS; Mylotarg Study Group.

Pharmacotherapy. 2001 Oct;21(10):1175-80.

PMID:
11601662
22.

Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P.

J Clin Pharmacol. 1999 Mar;39(3):281-8.

PMID:
10073328
23.

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC, Grebow PE.

J Clin Pharmacol. 1999 Jan;39(1):30-40.

PMID:
9987698
24.

Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers.

Wong YN, King SP, Laughton WB, McCormick GC, Grebow PE.

J Clin Pharmacol. 1998 Mar;38(3):276-82.

PMID:
9549666
25.

Carbohydrate Content and Enzyme Metabolism in Developing Canola Siliques.

King SP, Lunn JE, Furbank RT.

Plant Physiol. 1997 May;114(1):153-160.

26.

Degradation kinetics and mechanisms of moricizine hydrochloride in acidic medium.

King SP, Sigvardson KW, Dudzinski J, Torosian G.

J Pharm Sci. 1992 Jun;81(6):586-91.

PMID:
1522500
27.

Coronary angioplasty: long-term survival compared with coronary bypass surgery.

King SP 3rd.

Trans Assoc Life Insur Med Dir Am. 1989;72:88-94. Review. No abstract available.

PMID:
2525832
29.

The effect of a new anti-inflammatory agent (5-cyclohexylindan-1-carboxylic acid (BL-2365)) on platelet aggregation.

Fleming JS, Bierwagen ME, Campbell JA, King SP.

Arch Int Pharmacodyn Ther. 1972 Sep;199(1):164-71. No abstract available.

PMID:
5072183
30.

The effects of three anti-inflammatory agents on platelet aggregation, in vitro and in vivo.

Fleming JS, Bierwagen ME, Losada M, Campbell JA, King SP, Pindell MH.

Arch Int Pharmacodyn Ther. 1970 Jul;186(1):120-8. No abstract available.

PMID:
5528796

Supplemental Content

Support Center